Showing results (91-100 of 11,526) with videos related to

Sort By:
Pageof 1,153
British Journal of Clinical Pharmacology|March 26, 2019
Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL studyCaroline Victorri-Vigneau, Céline Verstuyft, Régis Bouquié, et al.
British Journal of Clinical Pharmacology|March 26, 2019
Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta-analysisMariana M Fachi, Fernanda S Tonin, Leticia P Leonart, et al.
British Journal of Clinical Pharmacology|July 1, 1986
Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugsR N Ratnaike, G J Schapel, G Purdie, et al.
British Journal of Clinical Pharmacology|February 28, 2019
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patientsFélicien Le Louedec, Catherine Alix-Panabières, Thierry Lafont, et al.
British Journal of Clinical Pharmacology|March 1, 2019
Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestineValérie Clermont, Alexia Grangeon, Azemi Barama, et al.
British Journal of Clinical Pharmacology|August 28, 2019
Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testingJames E Kimpton, Iain M Carey, Christopher J D Threapleton, et al.
British Journal of Clinical Pharmacology|August 20, 2019
Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed modelPhilip A Hines, Richard H Guy, Angela Brand, et al.
British Journal of Clinical Pharmacology|September 6, 2019
The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysisCaroline A Walsh, Caitriona Cahir, Sarah Tecklenborg, et al.
British Journal of Clinical Pharmacology|January 19, 2021
Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UKEssra Youssef, Charlotte L Kirkdale, David J Wright, et al.
British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Pageof 1,153